138 related articles for article (PubMed ID: 21074902)
21. Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients.
Lattante S; Le Ber I; Camuzat A; Pariente J; Brice A; Kabashi E;
Neurobiol Aging; 2013 Aug; 34(8):2078.e5-6. PubMed ID: 23582661
[TBL] [Abstract][Full Text] [Related]
22. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Rubino E; Rainero I; Chiò A; Rogaeva E; Galimberti D; Fenoglio P; Grinberg Y; Isaia G; Calvo A; Gentile S; Bruni AC; St George-Hyslop PH; Scarpini E; Gallone S; Pinessi L;
Neurology; 2012 Oct; 79(15):1556-62. PubMed ID: 22972638
[TBL] [Abstract][Full Text] [Related]
23. Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis.
Belzil VV; Daoud H; Desjarlais A; Bouchard JP; Dupré N; Camu W; Dion PA; Rouleau GA
Neurobiol Aging; 2011 Mar; 32(3):555.e13-4. PubMed ID: 21074290
[TBL] [Abstract][Full Text] [Related]
24. Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China.
Li C; Ji Y; Tang L; Zhang N; He J; Ye S; Liu X; Fan D
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):485-9. PubMed ID: 26503823
[TBL] [Abstract][Full Text] [Related]
25. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
[TBL] [Abstract][Full Text] [Related]
26. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients.
van Blitterswijk M; van Vught PW; van Es MA; Schelhaas HJ; van der Kooi AJ; de Visser M; Veldink JH; van den Berg LH
Neurobiol Aging; 2012 May; 33(5):1016.e1-7. PubMed ID: 21802176
[TBL] [Abstract][Full Text] [Related]
27. Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients.
Dillen L; Van Langenhove T; Engelborghs S; Vandenbulcke M; Sarafov S; Tournev I; Merlin C; Cras P; Vandenberghe R; De Deyn PP; Jordanova A; Cruts M; Van Broeckhoven C; van der Zee J;
Neurobiol Aging; 2013 Jun; 34(6):1711.e1-5. PubMed ID: 23312802
[TBL] [Abstract][Full Text] [Related]
28. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
29. Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.
Toth RP; Atkin JD
Front Immunol; 2018; 9():1017. PubMed ID: 29875767
[TBL] [Abstract][Full Text] [Related]
30. p62/SQSTM1 analysis in frontotemporal lobar degeneration.
Miller L; Rollinson S; Callister JB; Young K; Harris J; Gerhard A; Neary D; Richardson A; Snowden J; Mann DM; Pickering-Brown SM
Neurobiol Aging; 2015 Mar; 36(3):1603.e5-9. PubMed ID: 25433461
[TBL] [Abstract][Full Text] [Related]
31. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
[TBL] [Abstract][Full Text] [Related]
32. Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations.
Deng HX; Bigio EH; Zhai H; Fecto F; Ajroud K; Shi Y; Yan J; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Arch Neurol; 2011 Aug; 68(8):1057-61. PubMed ID: 21825243
[TBL] [Abstract][Full Text] [Related]
33. Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report.
Pottier C; Rampersaud E; Baker M; Wu G; Wuu J; McCauley JL; Zuchner S; Schule R; Bermudez C; Hussain S; Cooley A; Wallace M; Zhang J; Taylor JP; Benatar M; Rademakers R
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):469-471. PubMed ID: 29558868
[TBL] [Abstract][Full Text] [Related]
34. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration in association with CADASIL.
Kim HJ; Kim HY; Paek WK; Park A; Young Park M; Ki CS; Park HM; Kim SH
Neurologist; 2012 Mar; 18(2):92-5. PubMed ID: 22367839
[TBL] [Abstract][Full Text] [Related]
35. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
Chiang HH; Forsell C; Lilius L; Öijerstedt L; Thordardottir S; Shanmugarajan K; Westerlund M; Nennesmo I; Thonberg H; Graff C
Eur J Hum Genet; 2013 Nov; 21(11):1260-5. PubMed ID: 23463024
[TBL] [Abstract][Full Text] [Related]
36. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
[TBL] [Abstract][Full Text] [Related]
37. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of VCP and WASH complex genes in a German cohort of sporadic ALS-FTD patients.
Türk M; Schröder R; Khuller K; Hofmann A; Berwanger C; Ludolph AC; Dekomien G; Müller K; Weishaupt JH; Thiel CT; Clemen CS
Neurobiol Aging; 2017 Aug; 56():213.e1-213.e5. PubMed ID: 28551275
[TBL] [Abstract][Full Text] [Related]
39. Genetic contribution of FUS to frontotemporal lobar degeneration.
Van Langenhove T; van der Zee J; Sleegers K; Engelborghs S; Vandenberghe R; Gijselinck I; Van den Broeck M; Mattheijssens M; Peeters K; De Deyn PP; Cruts M; Van Broeckhoven C
Neurology; 2010 Feb; 74(5):366-71. PubMed ID: 20124201
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis.
Van Damme P; Robberecht W
Curr Opin Neurol; 2013 Oct; 26(5):466-72. PubMed ID: 23945281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
